24 Recruiting Now
Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Showing 100 of 140 trials
Active, Not Recruiting·N/A·Other
Pediatric Spinal Muscular Atrophy (SMA) China Registry
Biogen
Muscular Atrophy, Spinal
Unknown·Phase 1·Other
Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)
Hospital Universitario San Ignacio
Neoplasm, StomachGastric Neoplasms MalignantPancreatic Neoplasms+6 more
Completed·Phase 3·DMT
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Genentech, Inc.
Multiple Sclerosis, Relapsing-Remitting
Completed·N/A·Other
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies
Novartis
Multiple Sclerosis
Terminated·N/A·Other
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
Biogen
Multiple Sclerosis (MS)
Completed·N/A·DMT
Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration
University Hospital, Caen
C10.114.375.500
Terminated·Phase 2·DMT
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH Research Ireland Limited
Postpartum DepressionPostnatal Depression
Unknown·N/A·psilocybin
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
Imperial College London
Fibromyalgia
Completed·Phase 2·psilocybin
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Depressive SymptomsAnxietyCancer
Terminated·Phase 4·Other
Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Relapsing Remitting Multiple Sclerosis
Recruiting·Phase 3·DMT
Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)
Rennes University Hospital
Multiple Sclerosis
Not Yet Recruiting·Phase 1·Other
Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
Assistance Publique Hopitaux De Marseille
MedulloblastomaEpendymoma
Completed·N/A·psilocybin
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Johns Hopkins University
Nicotine Dependence
Completed·N/A·Other
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia
Hebei Province Veterans Hospital
Schizophrenia
Completed·N/A·Other
Dance Movement Therapy in the Treatment of Depressed Patients: A Randomised Controlled Trial
University of Jyvaskyla
Depression
Unknown·Early Phase 1·Other
Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy
Singapore National Eye Centre
Fuchs' Endothelial Dystrophy
Completed·Phase 4·Other
Natalizumab Temporary Discontinuation Study
University at Buffalo
Multiple Sclerosis
Unknown·N/A·Other
Personality and Drug Use
Psychedelic Data Society
No Conditions Study Focus on Substance Use and Personality
Not Yet Recruiting·Phase 3·DMT
Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)
University Hospital, Strasbourg, France
Relapsing-remitting Multiple Sclerosis (RRMS)
Not Yet Recruiting·N/A·Other
Cladribine Tablets as an Exit Therapy Strategy
University Hospital, Strasbourg, France
Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Withdrawn·Phase 2·ibogaine
Trifecta Research Study
Johns Hopkins University
PTSD - Post Traumatic Stress DisorderCognitive DysfunctionBrain Trauma+1 more
Completed·N/A·Other
Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry
Novartis
Sickle Cell Disease
Unknown·Phase 2·ayahuasca
Ayahuasca Assisted Psychotherapy for Grief
Beckley Med Foundation
Bereavement
Completed·N/A·DMT
Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis
Novartis
Multiple Sclerosis
Completed·Phase 1·ayahuasca
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach
Insel Gruppe AG, University Hospital Bern
Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine
Completed·N/A·Other
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
John F. Foley, MD
Multiple Sclerosis
Completed·N/A·DMT
Prospective Stratification of Infectious Risks in Multiple Sclerosis
University Hospital, Basel, Switzerland
Multiple Sclerosis
Terminated·Phase 2·DMT
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
Biogen
Multiple Sclerosis
Completed·N/A·Other
Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants
Biogen
Relapsing Remitting Multiple Sclerosis
Completed·Phase 1·DMT
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
GH Research Ireland Limited
Healthy Volunteers
Completed·N/A·psilocybin
Effects Of Dance Movement Therapy On Compassionate Flow In Nursing Students
Mackay Medical College
CompassionEducational ProblemsCompetence
Completed·Phase 1·Other
IM and IV SPL026 Drug Product in Healthy Participants
Small Pharma Ltd
Major Depressive Disorder
Completed·Phase 1·DMT
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Biomind Labs Inc.
Mild Cognitive ImpairmentAnxiety StateDepression Anxiety Disorder
Unknown·N/A·DMT
Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs
Max Nieuwdorp
Upper Respiratory Tract Infection
Completed·N/A·DMT
An Intervention Integrating Physical Therapy Exercise and Dance Movement Therapy for Preventing Falls in Older Adults
University of Haifa
Older Adults
Active, Not Recruiting·N/A·DMT
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Bristol-Myers Squibb
Multiple Sclerosis
Recruiting·Phase 1·psilocybin
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Johns Hopkins University
Healthy
Completed·N/A·Other
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.
IRCCS Centro Neurolesi Bonino Pulejo
Multiple Sclerosis
Completed·Phase 3·DMT
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Hoffmann-La Roche
Multiple Sclerosis, Relapsing-Remitting
Completed·N/A·DMT
Dance and Movement Therapy in Patients With Schizophrenia
Amasya University
SchizophreniaNegative Symptoms in SchizophreniaDisabilities Mental+1 more
Unknown·N/A·Other
Neurophysiological Assessment in Patients With Multiple Sclerosis
University of Roma La Sapienza
Multiple SclerosisDemyelinating DiseaseInflammatory Disease
Completed·Phase 4·Other
A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720
Novartis Pharmaceuticals
Multiple SclerosisRelapsing-Remitting
Recruiting·N/A·psilocybin
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
OCDMajor Depressive Disorder (MDD)Alcohol Use Disorder (AUD)+8 more
Completed·N/A·DMT
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)
Delphinus Medical Technologies, Inc.
Breast Cancer DetectionDense Breast ParenchymaBenign Breast Findings+2 more
Completed·Phase 1·DMT
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
Biomind Labs Inc.
Healthy Volunteers
Completed·N/A·DMT
Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients
Merck KGaA, Darmstadt, Germany
Relapsing Multiple Sclerosis
Active, Not Recruiting·Phase 2·psilocybin
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Johns Hopkins University
Major Depressive DisorderAlcohol Use Disorder
Unknown·N/A·Other
COVID-19 and Multiple Sclerosis Disease Modifying Therapies
Nottingham University Hospitals NHS Trust
Covid19Multiple Sclerosis
Completed·Phase 3·Other
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Celgene
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Completed·N/A·DMT
Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study
University of Utah
Premature Birth of Newborn
Completed·N/A·Other
Effectiveness of Digital Manipulation of Thyroid Cartilage and Fluency Shaping Therapy for the Management of Stuttering in Adult
Isra University
Developmental Stuttering
Completed·N/A·DMT
Programme Evaluation on Effectiveness of The Use of Movement-based x 'Elderspirituality - Fu Le Mun Sum' Intervention to Support Elderly People With Depressive Symptoms
The University of Hong Kong
Depression in Old Age
Completed·Phase 1·DMT
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
Pharmacokinetics in Healthy Adults
Completed·N/A·Other
Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study
University of British Columbia
Multiple SclerosisSkin CancerSkin Cancer Melanoma+3 more
Recruiting·Phase 1·psilocybin
Psilocybin Therapy for Chronic Low Back Pain
Joshua Woolley, MD, PhD
Chronic Low-back Pain
Active, Not Recruiting·N/A·Other
Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years
Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Unknown·N/A·DMT
Unified Cognitive-Behavioral Therapy (CBT) vs. Combined CBT and Dance/Movement Therapy (DMT) for Anxiety Disorders
Shalvata Mental Health Center
Anxiety Disorders
Completed·N/A·Other
Biogen Multiple Sclerosis Pregnancy Exposure Registry
Biogen
Multiple SclerosisExposure During Pregnancy
Completed·Phase 1·DMT
SPL026 With or Without SSRIs in Participants With MDD
Small Pharma Ltd
Major Depressive Disorder
Recruiting·N/A·Other
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Biogen
Multiple Sclerosis
Terminated·Phase 1·Other
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis
Jeffrey Gelfand
Relapsing Remitting Multiple Sclerosis
Completed·N/A·Other
A Study of Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies
Novartis Pharmaceuticals
Muscular Atrophy, Spinal
Recruiting·Phase 1·DMT
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Deepak C. D'Souza
Major Depression DisorderDepression
Completed·Phase 1·psilocybin
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Anxiety
Enrolling by Invitation·N/A·DMT
Relationship Between Oral DMT Burden and Adherence in MS
Monash University
Multiple SclerosisAdherence, Medication
Active, Not Recruiting·Phase 1·Other
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
Abu Dhabi Stem Cells Center
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Active, Not Recruiting·Phase 2·Other
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
University of Utah
Hypoxic-Ischemic EncephalopathyPain
Active, Not Recruiting·N/A·Other
Covid-19 Vaccine Immune Response in Multiple Sclerosis
University Hospitals of North Midlands NHS Trust
Multiple Sclerosis
Completed·Early Phase 1·ayahuasca
Mindfulness and Psychedelics
Milan Scheidegger
Healthy Participants
Completed·Phase 2·DMT
A Trial of GH001 in Patients With Treatment-resistant Depression
GH Research Ireland Limited
Treatment-resistant Depression
Completed·Phase 1·DMT
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
Usona Institute
PharmacokineticsSafetyTolerability
Active, Not Recruiting·Phase 1·DMT
Single and Repeat Doses of DMT in Healthy Subjects
Algernon Pharmaceuticals
Stroke
Recruiting·Phase 3·DMT
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Recruiting·Phase 2·psilocybin
Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
Parkinson DiseaseDepression
Terminated·Phase 2·DMT
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
GH Research Ireland Limited
Bipolar II Disorder
Recruiting·Phase 1·psilocybin
Investigation of Psychedelic Effects in Psychoactive Substances
Johns Hopkins University
Psychedelic Effects in Healthy Volunteers
Recruiting·N/A·Other
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Biogen
Multiple Sclerosis
Completed·Phase 1·DMT
Clinical Study of DMT in Healthy Adults
Biomind Labs Inc.
Healthy Volunteers
Active, Not Recruiting·Phase 1·DMT
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Yale University
Major Depressive DisorderDepression
Recruiting·N/A·DMT
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
University of Rochester
Sickle Cell Disease (SCD)
Completed·N/A·DMT
The 'Wearing Off' Effect of DMT
Novartis Pharmaceuticals
Multiple Sclerosis
Completed·Early Phase 1·DMT
Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
Psychiatric University Hospital, Zurich
EmotionsMoodCognitive Function 1, Social+1 more
Completed·N/A·DMT
Dance Movement Therapy for Radio-oncological Patients
University of Erlangen-Nürnberg Medical School
Cancer Patients and Physical Activity
Completed·Phase 1·DMT
SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Small Pharma Ltd
Major Depressive Disorder
Withdrawn·N/A·Other
Personality and Drug Use (PDU)
Quantified Citizen Technologies Inc.
Personality
Unknown·N/A·DMT
Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain
Drexel University
Chronic Low-back Pain
Recruiting·Phase 1·DMT
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Yale University
Alcohol Use Disorder (AUD)Alcohol-Related DisordersAlcohol Use
Completed·N/A·DMT
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
University of Colorado, Denver
Multiple Sclerosis
Unknown·N/A·Other
MIH and Hypersensitivity in Children
Università degli Studi di Brescia
Dentin SensitivityMolar Incisor Hypomineralization
Completed·Phase 1·DMT
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
University Hospital, Basel, Switzerland
Healthy
Completed·N/A·Other
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition
Hoffmann-La Roche
Multiple Sclerosis, Relapsing-Remitting
Active, Not Recruiting·Phase 2·DMT
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)
Cybin IRL Limited
Generalized Anxiety Disorder
Completed·Phase 3·DMT
The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause
University Health Network, Toronto
Bone DensityOsteopeniaOsteoporosis+1 more
Terminated·Phase 2·Other
Neuroprotection and Repair in Optic Neuritis
University of Calgary
Multiple SclerosisOptic Neuritis
Completed·Phase 4·Other
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
State University of New York at Buffalo
Multiple Sclerosis
Recruiting·Phase 1·ketamine
Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants
University Hospital, Basel, Switzerland
Healthy
Active, Not Recruiting·N/A·Other
Adult Spinal Muscular Atrophy (SMA) China Registry
Biogen
Muscular Atrophy, Spinal
Completed·Phase 1·Other
Single Ascending Dose Study With BPL-003 in Healthy Subjects
Beckley Psytech Limited
Pharmacokinetics in Healthy Adults
Completed·Early Phase 1·psilocybin
Psilocybin Cancer Anxiety Study
NYU Langone Health
Cancer
Completed·Phase 1·DMT
Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects
Reconnect Labs
Healthy
More trials available. Refine your search to see specific results.
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.